The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Optical Genome Mapping Market Be By 2030 Compared To Its 2026 Market Size?
The optical genome mapping market has expanded significantly in recent years. This market is projected to increase from $0.23 billion in 2025 to $0.29 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 29.4%. Historically, this growth has been fueled by factors such as the limitations of next generation sequencing in detecting large structural variants, increasing genomic research funding, the rising prevalence of genetic disorders, a growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling.
The optical genome mapping market size is projected to experience substantial growth over the coming years. By 2030, it is anticipated to reach $0.74 billion, exhibiting a compound annual growth rate (CAGR) of 25.9%. This expansion during the forecast period is driven by factors such as the increasing incorporation of OGM in clinical laboratories, greater investment in precision medicine programs, a rise in the uptake of automated genomic analysis platforms, broadening applications within oncology and hematological malignancies, and a decrease in the expenses associated with genomic analysis technologies. Key developments expected during this period include the expanding utilization of optical genome mapping for structural variant detection, its growing application in rare disease and cancer research, an escalating demand for high-resolution long-read genomic analysis, the extension of OGM applications into clinical diagnostics, and an increasing inclination towards using OGM in conjunction with sequencing technologies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp
Which Factors Are Influencing The Growth Of The Optical Genome Mapping Market?
A key factor anticipated to drive the future expansion of the optical genome mapping market is the rising demand for precision medicine. Precision medicine represents a healthcare strategy tailored to individual traits, including genetic composition, lifestyle choices, and environmental factors, for medical treatment and prevention. The need for precision medicine is fueled by several factors: a growing incidence of chronic illnesses, innovations in genomic technologies, greater investment and funding, and patients’ desire for customized care. optical genome mapping boosts the effectiveness of precision medicine by offering a precise and thorough insight into genomic changes linked to diverse diseases. As an illustration, data from February 2024, shared by the US-based non-profit Personalized Medicine Coalition, revealed that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the heightened demand for precision medicine is acting as a catalyst for the growth of the optical genome mapping market.
Which Segments Define The Optical Genome Mapping Market Segment Structure?
The optical genome mapping market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software, Services
2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices
2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells
3) By Software: Data Analysis Software, Image Processing Software, Mapping Software
4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services
Which Trends Are Influencing Demand In The Optical Genome Mapping Market?
Leading companies in the optical genome mapping (OGM) market are concentrating on developing technological advancements, specifically OGM-based laboratory-developed tests (LDTs) for genome-wide structural variant detection. These efforts aim to enhance diagnostic accuracy, improve workflow efficiency, and lessen dependence on multiple traditional cytogenetic tests. An OGM-based LDT functions by utilizing ultra-long, high-molecular-weight DNA molecules which are fluorescently labeled and then linearized in nanochannels. This method facilitates high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions across the genome, features often overlooked by short-read sequencing or microarrays. For instance, in March 2023, Bionano Laboratories, a U.S.-based CLIA-certified subsidiary of Bionano Genomics, introduced the OGM Dx Postnatal Whole Genome SV test. This product allows for genome-wide detection of structural variants in patients suffering from developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or undiagnosed genetic conditions. It integrates high-resolution OGM with variant calling in a single-test workflow, thereby reducing the need for numerous classical cytogenetic assays and offering quicker, more comprehensive diagnostic insights.
Who Are The Established Players Within The Optical Genome Mapping Market?
Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics
Get The Full Optical Genome Mapping Market Report:
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report
Which Region Leads The Optical Genome Mapping Market In Overall Market Size?
North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Optical Genome Mapping Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report
Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company
Optic Atrophy Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report
Peripheral Neuropathy Market Report
https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report
Diabetic Neuropathy Market Report
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model